(1-甲基环己基)溴化镁 | 424788-83-0

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机溴化物
• 中文名称: (1-甲基环己基)溴化镁
• 英文名称: (1-methylcyclohexyl)magnesium bromide
• CAS: 424788-83-0
• 化学式: C₇H₁₃BrMg
• 分子量: 201.389
• InChiKey: GUYBAEIMEFEKQT-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  3.14
• 重原子数：
  9.0
• 可旋转键数：
  1.0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0.0
• 氢给体数：
  0.0
• 氢受体数：
  0.0

反应信息

• 作为反应物：
  描述：

  (1-甲基环己基)溴化镁 、 二甲基二氯化锡 以27%的产率得到
  参考文献：
  名称：

  EL-FARARGY, A. F.;NEUMANN, W. P., J. ORGANOMET. CHEM., 1983, 258, N 1, 15-19

  摘要：

  DOI：

文献信息

• [EN] CARBOXYLIC ACID-CONTAINING COMPOUNDS, DERIVATIVES THEREOF, AND RELATED METHODS OF USE<br/>[FR] COMPOSÉS CONTENANT DE L'ACIDE CARBOXYLIQUE, LEURS DÉRIVÉS ET PROCÉDÉS D'UTILISATION ASSOCIÉS
  申请人：BIOGEN IDEC INC

  公开号：WO2010138901A1

  公开（公告）日：2010-12-02

  Compounds that modulate gamma secretase (e.g., alter the cleavage pattern of gamma secretase) are described herein. Also disclosed are pharmaceutical compositions, methods of modulating the activity of gamma secretase, and methods of treating Alzheimer's Disease using the compounds described herein.

  本文件描述了调节γ-分泌酶（例如，改变γ-分泌酶的切割模式）的化合物。还公开了包含这些化合物的药物组合物、调节γ-分泌酶活性的方法，以及使用本文件描述的化合物治疗阿尔茨海默病的方法。
• Production processes for triorganomonoalkoxysilanes and triorganomonochlorosilanes
  申请人：Bannou Tadashi

  公开号：US20050070730A1

  公开（公告）日：2005-03-31

  A silane containing a bulky hydrocarbon group or groups R therein and having the formula (III) R 3-(x+y) (R 1 ) x (R 2 ) y Si(OR 3 ) can be produced by reacting a silane of the formula (I) (R 1 ) x (R 2 ) y SiCl 3-(x+y) (OR 3 ) with a Grignard reagent of the formula (II) RMgX Further, a tri-organo-chlorosilane of the formula (XIIa) (R 1 )(R 2 )(R 3 )SiCl can be produced by reacting a tri-organo-silane of the formula (XIa) (R 1 )(R 2 )(R 3 )SiZ 1 with hydrochloric acid. Furthermore, a tri-organo-monoalkoxysilane of the formula (XXIII) R 3-(x+y) (R 1 ) x (R 2 ) y Si(OR 3 ) can be produced when a silane of the formula (XXI) (R 1 ) x (R 2 ) y SiCl 4-(x+y) is reacted with a Grignard reagent of the formula (XXII) RMgX with addition of and reaction with an alcohol or an epoxy compound during the reaction.

  含有庞大烃基或基团R的硅烷，其具有式(III)R3-(x+y)(R1)x(R2)ySi(OR3)，可通过反应式(I)(R1)x(R2)ySiCl3-(x+y)(OR3)的硅烷与式(II)RMgX的格氏试剂制得。此外，式(XIIa)(R1)(R2)(R3)SiCl的三有机氯硅烷可通过反应式(XIa)(R1)(R2)(R3)SiZ1的三有机硅烷与盐酸制得。再者，当式(XXI)(R1)x(R2)ySiCl4-(x+y)的硅烷与式(XXII)RMgX的格氏试剂反应，并在反应过程中加入并反应酒精或环氧化合物时，可制得式(XXIII)R3-(x+y)(R1)x(R2)ySi(OR3)的三有机单烷氧基硅烷。
• ISOQUINOLINE COMPOUNDS, A PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
  申请人：LES LABORATOIRES SERVIER

  公开号：US20170137385A1

  公开（公告）日：2017-05-18

  A compound of formula (I): wherein the substituents are as defined in the description. Medicinal products containing the same which are useful in treating or preventing pathologies which are the result of activation of the RhoA/ROCK pathway and phosphorylation of the myosin light chain.

  式（I）的化合物：其中取代基如描述中所定义。含有相同化合物的药品，可用于治疗或预防由RhoA/ROCK途径的激活和肌球蛋白轻链的磷酸化所导致的病理。
• PROCESSES FOR THE PRODUCTION OF TRI-ORGANO-MONOALKOXYSILANES AND PROCESS FOR THE PRODUCTION OF TRI-ORGANO-MONOCHLOROSILANES
  申请人：Bannou Tadashi

  公开号：US20090082585A1

  公开（公告）日：2009-03-26

  A silane containing a bulky hydrocarbon group or groups R therein and having the formula (III) R 3−(x+y) (R 1 ) x (R 2 ) y Si(OR 3 ) can be produced by reacting a silane of the formula (I) (R 1 ) x (R 2 ) y SiCl 3−(x+y) (OR 3 ) with a Grignard reagent of the formula (II) RMgX Further, a tri-organo-chlorosilane of the formula (XIIa) (R 1 )(R 2 )(R 3 )SiCl can be produced by reacting a tri-organo-silane of the formula (XIa) (R 1 )(R 2 )(R 3 )SiZ 1 with hydrochloric acid. Furthermore, a tri-organo-monoalkoxysilane of the formula (XXIII) R 3−(x+y) (R 1 ) x (R 2 ) y Si(OR 3 ) can be produced when a silane of the formula (XXI) (R 1 ) x (R 2 ) y SiCl 4−(x+y) is reacted with a Grignard reagent of the formula (XXII) RMgX with addition of and reaction with an alcohol or an epoxy compound during the reaction.

  含有笨重烃基团R的硅烷化合物，其化学式为(III)R3−(x+y)(R1)x(R2)ySi(OR3)，可以通过将化学式为(I)(R1)x(R2)ySiCl3−(x+y)(OR3)的硅烷与化学式为(II)RMgX的格氏试剂反应来制备。此外，可以通过将化学式为(XIa)(R1)(R2)(R3)SiZ1的三元有机硅烷与盐酸反应来制备化学式为(XIIa)(R1)(R2)(R3)SiCl的三元有机氯硅烷。此外，在反应过程中加入醇或环氧化合物，可以通过将化学式为(XXI)(R1)x(R2)ySiCl4−(x+y)的硅烷与化学式为(XXII)RMgX的格氏试剂反应来制备化学式为(XXIII)R3−(x+y)(R1)x(R2)ySi(OR3)的三元有机单烷氧基硅烷。
• Dioxolane derivatives for use as chemical intermediates
  申请人：IMPERIAL CHEMICAL INDUSTRIES PLC

  公开号：EP0037697A1

  公开（公告）日：1981-10-14

  The invention is concerned with novel dioxolane derivatives of the formula:- in which Ra is hydrogen or (1-4C)alkyl and Rb is (1-4C)alkyl or phenyl optionally bearing a halogeno substituent; their production; and their use for the manufacture of certain known anti-arthritic acids of the formula:- and, in particular, those acids in which Ra=Rb=methyl or Ra=ethyl and Rb =phenyl, by a novel reduction process. The preferred reduction procedures involve the use of an alkali metal borohydride or cyanoborohydride in the presence of a noble metal catalyst, or the use of an α-branched alkyl or cycloalkyl Grignard agent. The use of the derivatives of formula avoids the need for potentially toxic reagents and reactive intermediates in the previously known processes for the production of the acids of formula V.

  本发明涉及式如下的新型二氧戊环衍生物 其中Ra为氢或(1-4C)烷基，Rb为(1-4C)烷基或任选带有卤代基的苯基；它们的生产；以及它们用于制造某些已知的式为:-的抗关节炎酸。 特别是Ra＝Rb＝甲基或Ra＝乙基和Rb＝苯基的那些酸，采用新的还原工艺。优选的还原过程包括在贵金属催化剂存在下使用碱金属硼氢化物或氰基硼氢化物，或使用 α-支链烷基或环烷基格氏剂。 使用式的衍生物可以避免在以前已知的生产式 V 酸的工艺中使用可能有毒的试剂和反应中间体。